ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evolva restructures as part of sales drive

by Melody M. Bomgardner
September 4, 2017 | APPEARED IN VOLUME 95, ISSUE 35

The Swiss industrial biotech firm Evolva will reduce its workforce to 100 employees, from 178, to focus on commercializing its fermentation-derived food ingredients and increasing sales. The company makes food and nutraceutical ingredients including resveratrol, stevia, and vanillin via fermentation with modified microbes. Evolva named a new CEO in July; three other executives will step down by the end of the year. Evolva will also consolidate research activities at its headquarters in Reinach.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment